statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	935
SG - Singapore	162
VN - Vietnam	129
IT - Italia	96
CN - Cina	77
RU - Federazione Russa	71
BR - Brasile	60
HK - Hong Kong	44
DE - Germania	34
GB - Regno Unito	29
FI - Finlandia	25
FR - Francia	24
SE - Svezia	18
LV - Lettonia	12
ID - Indonesia	11
KR - Corea	10
NL - Olanda	10
CA - Canada	9
IN - India	9
AR - Argentina	8
ES - Italia	8
AT - Austria	7
PL - Polonia	7
AU - Australia	6
BD - Bangladesh	6
CZ - Repubblica Ceca	6
EC - Ecuador	6
MX - Messico	6
ZA - Sudafrica	6
IQ - Iraq	5
BG - Bulgaria	4
CH - Svizzera	4
IL - Israele	4
PH - Filippine	4
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
CL - Cile	2
CO - Colombia	2
DZ - Algeria	2
JP - Giappone	2
KE - Kenya	2
KZ - Kazakistan	2
LT - Lituania	2
RO - Romania	2
SK - Slovacchia (Repubblica Slovacca)	2
TR - Turchia	2
AF - Afghanistan, Repubblica islamica di	1
AZ - Azerbaigian	1
CU - Cuba	1
DK - Danimarca	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
MA - Marocco	1
MD - Moldavia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PY - Paraguay	1
RS - Serbia	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.895

Nome	#
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface	231
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models	231
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles	194
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine	192
Vaccinology: The art of putting together the right ingredients	180
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli	175
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform	166
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	163
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells	118
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine	104
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles	100
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells	83
Totale	1.937

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	31	0	0	0	0	0	0	0	0	0	0	0	31
2021/2022	111	7	7	2	6	7	7	2	16	12	13	11	21
2022/2023	145	21	15	8	27	5	26	0	11	14	1	7	10
2023/2024	78	1	4	2	2	1	25	5	6	2	11	2	17
2024/2025	372	7	1	31	70	12	39	4	17	12	70	24	85
2025/2026	858	73	33	90	159	81	58	170	22	65	61	28	18
Totale													1.937